GERN
NASDAQ · Biotechnology
Geron Corp
$0.99
+0.04 (+4.18%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,820.6% upside
Low Target
$12.94
Average Target
$19.01
High Target
$24.33
Current Price
$0.99
Current
$0.99
$0.99
Target
$19.01
$19.01
$12.94
$19.01 avg
$24.33
Scenario Analysis
Bear Case
$12.94
1,207.3%
Low target
Base Case
$19.01
+1,820.6%
Avg target
Bull Case
$24.33
+2,358.1%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$2.01
-50.8% from high
52-Week Low
$0.84
+17.8% from low
Target vs 52W High
$19.01
+845.8% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-0.01
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |